Upstate Active Clinical Trials

Study Title:

Comparative Study of the Diagnostic Accuracy of Scintimammography (Technetium 99m-Sestamibi and Fluorine 18-FDG PET Scintigraphic Imaging) and Magnetic Resonance Imaging in Identifying Malignant Breast Lesions, in Subjects with Breast Abnormalities.

What is the purpose of the study?

Due to x-ray mammograms being difficult to interpret, this study will determine the diagnostic accuracy of breast Magnetic Resonance Imaging and Nuclear Medicine (including) PET imaging.

Upstate Institutional Review Board (IRB) Number:

264939

Study Phase:

N/A

Patient Age Group:

Adults

Principal Investigator:

David H Feiglin, MD

Who is eligible?

Difficult to interpret or non-interpretable mammogram (usually due to dense tissue in the breasts).

What is involved if I participate?

  • How long is the study?
    One Test
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    Nuclear medicine breast imaging, PET scan, magnetic resonance study.

Where will the study take place?

SUNY Upstate Medical University,Syracuse, NY

Other Information:

Who can I contact for more information?

Name: Susan A Hemingway
Phone: 315-464-5099
Email: hemingws@upstate.edu

Return to Previous Page || Search Again